Clinical Trials DEA History Legislation 
Americans for Safe Access
JUNE 2, 2020
On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.
Veriheal
JUNE 29, 2021
Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. Patients Are Not In This Alone.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
DECEMBER 21, 2022
This makes history by enacting the first piece of standalone federal cannabis reform legislation in U.S. The Drug Enforcement Administration (DEA) is now mandated to approve applications to be manufacturers of marijuana-derived, FDA-approved drugs under the bill. The law gives the U.S. The law gives the U.S.
Canna Law Blog
NOVEMBER 27, 2021
So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” Psychedelics Legislation Advances in California.
Canna Law Blog
JANUARY 3, 2023
A little CBD history. Until recently, CBD resided in a legal penumbra where hemp was still scheduled on the federal Controlled Substances Act and could not be cultivated without a permit from the Drug Enforcement Administration (“DEA”). ” What lies ahead for FDA and CBD regulation.
Cannabis Law Report
JULY 9, 2021
Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].
SpeedWeed
DECEMBER 28, 2018
Election Night also ushered in new, pro-legalization governors in so-far not legalized Illinois, Connecticut, Maine, Minnesota, and New Mexico, and also saw the defeat of staunch cannabis opponent Pete Sessions, who’s been blocking cannabis legislation for years. RELATED STORY. The Top 10 Cannabis Stories of 2018.
Expert insights. Personalized for you.
223 
Let's personalize your content